Home/Filings/4/0001140361-12-019210
4//SEC Filing

Angelo Beth 4

Accession 0001140361-12-019210

CIK 0001379246other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:23 PM ET

Size

22.0 KB

Accession

0001140361-12-019210

Insider Transaction Report

Form 4
Period: 2012-04-02
Angelo Beth
DirectorEVP and Chief Merch Officer
Transactions
  • Sale

    Common Stock

    2012-04-02$27.61/sh15,383$424,74996,623 total
  • Sale

    Common Stock

    2012-04-02$28.19/sh2,079$58,60394,544 total
  • Sale

    Common Stock

    2012-04-03$27.72/sh7,538$208,94294,544 total
  • Sale

    Common Stock

    2012-04-03$27.72/sh12,062$334,341282,621 total(indirect: See Note 5)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-04-022,462121,510 total
    Exercise: $3.94Exp: 2019-10-12Common Stock (2,462 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-04-037,538113,972 total
    Exercise: $3.94Exp: 2019-10-12Common Stock (7,538 underlying)
  • Exercise/Conversion

    Common Stock

    2012-04-02$3.94/sh+2,462$9,700112,006 total
  • Sale

    Common Stock

    2012-04-02$27.61/sh24,611$679,549298,010 total(indirect: See Note 5)
  • Sale

    Common Stock

    2012-04-02$28.19/sh3,327$93,782294,683 total(indirect: See Note 5)
  • Exercise/Conversion

    Common Stock

    2012-04-03$3.94/sh+7,538$29,700102,082 total
Footnotes (7)
  • [F1]Includes 8,435 restricted shares granted pursuant to the Company's Equity Incentive Plan. Shares vest 25% per year beginning on September 16, 2012.
  • [F2]The reported sales were made pursuant to Rule 10b5-1 trading plans.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.30 to $27.995, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.01 to $28.90, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F5]Shares are owned by the reporting person's father. The reporting person has sole voting and investment power of these shares.
  • [F6]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.97, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F7]Twenty-five percent of the shares underlying the option vested on October 12, 2010. The balance of the shares vest in 12 equal quarterly installments beginning January 12, 2011 and ending October 12, 2013.

Documents

1 file

Issuer

BODY CENTRAL CORP

CIK 0001379246

Entity typeother

Related Parties

1
  • filerCIK 0001503341

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:23 PM ET
Size
22.0 KB